Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
To overcome CKs poor bioavailability, an albumin-based nanoformulation (nabCK) was developed for improved hepatic targeting
2017;49(10):e12768
Claims for "Research Grade" Peptides in GLP-1 Drugs Another emerging legal issue involves claims for research-grade peptides sold as alternatives to FDA-approved GLP-1 medications
DNA-PKcs promotes sepsis-induced multiple organ failure by triggering mitochondrial dysfunction
US$ 27.41
US$ 21.68
US$ 20.75
US$ 23.56
US$ 24.66
US$ 27.13
US$ 22.65
